Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mingke Yu & Michael Vajdy. (2010) Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes. Expert Opinion on Biological Therapy 10:8, pages 1181-1195.
Read now
Read now
Thorsten Demberg & Marjorie Robert-Guroff. (2009) Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design. International Reviews of Immunology 28:1-2, pages 20-48.
Read now
Read now
Marc P. Girard & Geetha P. Bansal. (2008) HIV/AIDS Vaccines: A Need for New Concepts?. International Reviews of Immunology 27:6, pages 447-471.
Read now
Read now
Matthias Liniger, Armando Zuniga & Hussein Y Naim. (2007) Use of viral vectors for the development of vaccines. Expert Review of Vaccines 6:2, pages 255-266.
Read now
Read now
Articles from other publishers (17)
Xianliang Sun, Han Zhang, Shuiling Xu, Lili Shi, Jingjian Dong, Dandan Gao, Yan Chen & Hao Feng. (2017) Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses. Virology Journal 14:1.
Crossref
Crossref
Reinhard Pabst. (2015) Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)—Structure, function and species differences. Vaccine 33:36, pages 4406-4413.
Crossref
Crossref
Debra Tristram. 2015. Mucosal Immunology. Mucosal Immunology
2215
2229
.
Per Brandtzaeg. 2015. Mucosal Immunology. Mucosal Immunology
1985
2016
.
Teena Mohan, Priyanka Verma & D.N. Rao. (2014) Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides. Immunobiology 219:4, pages 292-301.
Crossref
Crossref
Teena Mohan, D. Mitra & D. N. Rao. (2013) Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1. Immunologic Research 58:1, pages 139-153.
Crossref
Crossref
Per Brandtzaeg. (2011) Potential of Nasopharynx-associated Lymphoid Tissue for Vaccine Responses in the Airways. American Journal of Respiratory and Critical Care Medicine 183:12, pages 1595-1604.
Crossref
Crossref
A. D. Cristillo, M. G. Ferrari, L. Hudacik, B. Lewis, L. Galmin, B. Bowen, D. Thompson, N. Petrovsky, P. Markham & R. Pal. (2010) Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. Journal of General Virology 92:1, pages 128-140.
Crossref
Crossref
Victor Raúl Gómez Román, Lasse Vinner, Berit Grevstad, Jesper Juhl Hansen, Frank Wegmann, Anna-Lena Spetz & Anders Fomsgaard. (2010) Development of standard operating procedures to obtain longitudinal vaginal specimens from nulliparous rabbits as part of HIV vaccine mucosal immunogenicity studies. Journal of Immunological Methods 363:1, pages 29-41.
Crossref
Crossref
Ali Azizi, Haitham Ghunaim, Francisco Diaz-Mitoma & Jiri Mestecky. (2010) Mucosal HIV vaccines: A holy grail or a dud?. Vaccine 28:24, pages 4015-4026.
Crossref
Crossref
Aurelio Cafaro, Iole Macchia, Maria Teresa Maggiorella, Fausto Titti & Barbara Ensoli. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
189
242
.
S.D. Klas, C.R. Petrie, S.J. Warwood, M.S. Williams, C.L. Olds, J.P. Stenz, A.M. Cheff, M. Hinchcliffe, C. Richardson & S. Wimer. (2008) A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge. Vaccine 26:43, pages 5494-5502.
Crossref
Crossref
Anna U. BielinskaKatarzyna W. JanczakJeffrey J. LandersDavid M. MarkovitzDavid C. MontefioriJames R. BakerJr.Jr.. (2008) Nasal Immunization with a Recombinant HIV gp120 and Nanoemulsion Adjuvant Produces Th1 Polarized Responses and Neutralizing Antibodies to Primary HIV Type 1 Isolates. AIDS Research and Human Retroviruses 24:2, pages 271-281.
Crossref
Crossref
Per Brandtzaeg & Finn-Eirik Johansen. 2008. Immunity Against Mucosal Pathogens. Immunity Against Mucosal Pathogens
33
76
.
Barbara Rath, Thomas Linder, David Cornblath, Michael Hudson, Rohini Fernandopulle, Katharina Hartmann, Ulrich Heininger, Hector Izurieta, Leslie Killion, Pangiotis Kokotis, James Oleske, Michael Vajdy & Virginia Wong. (2007) “All that palsies is not Bell's [1]”—The need to define Bell's palsy as an adverse event following immunization. Vaccine 26:1, pages 1-14.
Crossref
Crossref
Qifeng Zhou, Rachmat Hidajat, Bo Peng, David Venzon, M. Kristine Aldrich, Ersell Richardson, Eun Mi Lee, V.S. Kalyanaraman, George Grimes, V. Ra?l G?mez-Rom?n, L. Ebonita Summers, Nina Malkevich & Marjorie Robert-Guroff. (2007) Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIVmac251. Vaccine 25:47, pages 8021-8035.
Crossref
Crossref
Per Brandtzaeg. (2007) Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25:30, pages 5467-5484.
Crossref
Crossref